sik2ghjv | Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/sik2ghjv_hasAnnotation_C0013227>
?:creator	<https://research.tib.eu/covid-19/entity/Frega%2C_Giorgio%3B_Palloni%2C_Andrea%3B_Di_Pasquale%2C_Giuseppe%3B_Saccoccio%2C_Gioconda%3B_Rizzo%2C_Alessandro%3B_Poluzzi%2C_Elisabetta%3B_Iannone%2C_Primiano%3B_Brandi%2C_Giovanni>
?:doi	10.3389/fphar.2020.559996
?:doi	<https://research.tib.eu/covid-19/entity/10.3389/fphar.2020.559996>
?:journal	Front_Pharmacol
?:license	cc-by
?:pdf_json_files	document_parses/pdf_json/ae133d5c4a5cb7bfecc80d6ed1c3806ae1d1437e.json
?:pmc_json_files	document_parses/pmc_json/PMC7655924.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7655924>
?:pmid	<https://research.tib.eu/covid-19/entity/33192506.0>
?:pmid	33192506.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/sik2ghjv_HAS_C0013227_TREATS_C5203670>
?:sha_id	<https://research.tib.eu/covid-19/entity/ae133d5c4a5cb7bfecc80d6ed1c3806ae1d1437e>
?:source	Medline; PMC
?:title	Challenges in Repurposing Drugs in COVID-19 Pandemic. Debating on Potential New Refinements
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-10-28

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/sik2ghjv>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/sik2ghjv>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all